Doctor's Data offers scores of distinct tests across key categories:
Allergy & Immunology
Bloodspot
Cardiovascular
Clinical Microbiology

      
Endocrinology
Environmental Exposure/Detoxification
Nutritional
Toxic & Essential Elements

      
 

You Spoke - We Listened
 
Introducing Doctor's Data's Neuro-Biogenic Amine Profiles
providing an assessment of neurotransmitter metabolism

 

Recently many practitioners who rely on DDI for their functional testing have told us how important the assessment of neurotransmitter synthesis and metabolism is in their practice protocols.  They expressed a great desire to be able to source such testing from DDI given our longstanding reputation for quality and integrity.  We are pleased to be able to respond positively to this challenge by announcing the immediate availability of this important testing.  DDI employs superior technology and techniques to ensure accuracy and precision while providing enhanced reporting and customer support. Urinary neuro-biogenic amines provide insight into a patient's overall ability to synthesize and metabolize neurotransmitters.  Doctor's Data's Neuro-Biogenic Amine Profiles help identify alterations in urinary neurotransmitter status which may be associated with a variety of conditions from metabolic to behavioral disorders.

 
Value in Clinical Practice
 
Analysis of urinary neuro-biogenic amines and their metabolites provides a non-invasive assessment of neurotransmitter metabolism.
 
A review of current scientific literature indicates that neuro-biogenic amine testing may be useful in a variety of areas:

       
  • Functional testing—Neuro-biogenic amine metabolism may be mediated by catechol-O-methyltransferase (COMT), monoamine oxidase (MAO), and other enzymes. Test results may provide functional information about these important enzymes.
  • Imbalance identification—Research indicates that urinary neuro-biogenic amine levels may correlate with conditions such as depression and PTSD.
  • Response to therapy—Certain neuro-biogenic amines such as serotonin may be altered by the addition of neurotransmitter precursors such as 5-hydroxytryptophan (5-HTP). These changes may be apparent in the urine.
  • Toxicology risk assessment—Changes in urinary serotonin, dopamine, and glutamate levels have been suggested as biomarkers for neurobehavioral toxicology resulting from chemical or environmental exposures.
 

 

Doctor's Data offers Urinary Neuro-Biogenic Amine Profiles as a non-invasive way to assess the neurotransmitters essential for normal function.  Our profiles are designed to help you identify therapeutic opportunities to support your patients' health.
  
  

Neuro-Biogenic Amines in the Body
 
Neuro-biogenic amines are produced from essential aromatic amino acids and secreted from pre-synaptic neurons into the synapse between nerve cells to stimulate receptors on postsynaptic neurons. While circulating levels of neuro-biogenic amines and metabolites may have a variety of sources, urinary levels primarily reflect activity of the peripheral and enteric nervous systems. In fact, up to 20 percent of urinary neurotransmitters are estimated to originate in the central nervous system.

 
By measuring urinary neuro-biogenic amines, we can learn a great deal about a patient's ability to synthesize and metabolize neurotransmitters in the peripheral nervous system and behind the blood-brain barrier.
 
Neuro-biogenic amine levels may be influenced by diet, age, gender, body mass, kidney function, environmental exposures, infection, and tobacco use, as well as conditions such as metabolic disorders, mood or behavioral disorders, or in rare cases the presence of certain tumors.  As a result, evaluating urinary neuro-biogenic amines may offer increased clarity about a patient's health and functional status.


Neuro-Biogenic Amine Profiles and Test Components
 
 

 
 
Which profile to order?
 
The Comprehensive Profile includes additional catecholamine metabolites and metanephrines which provide expanded functional enzyme assessment.
 
 


Click image for more details about this test.

 
   
 
Follow links below to view other suggested Doctor's Data profiles:
 
 
Introducing Heather Cadwallader
 
Doctor's Data, Inc. has engaged the services of a Clinical Specialty Representative to assist you with our new Neuro-Biogenic Amine Profiles.  Heather Cadwallader has years of experience with this testing and its many uses and will be an invaluable resource for you.  Please click the following button to complete our contact request form.  Heather will reach out to you shortly about our Neuro-Biogenic Amine Profiles or other tests of interest.

 
 
   
 
Why choose Doctor's Data Inc.?
                                
Doctor's Data, Inc. has provided innovative specialty testing to healthcare practitioners around the world from our advanced CLIA-licensed clinical laboratory since 1972.

A specialist and pioneer in essential and toxic elemental testing, the laboratory provides a wide array of functional testing to aid in decision making and better patient outcomes.  Choose DDI to help you assess and treat heavy metal burden, nutritional deficiencies, gastrointestinal function, cardiovascular risk, liver and metabolic abnormalities, and more.